Development and evaluation of zopiclone compression coated tablet for time-controlled pulse release: Mechanism and in vivo study

Zhou, Yujie; Li, Le; Liu, Zheng; Wang, Qinying; Zhou, Qida

doi:10.1016/j.jddst.2020.101714

Cited by 4 publications

(2 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For screening, 0.5 g of the lipid was melted at 80 °C, and then, in 1 mL of acetone, 10 mg of ZP was dissolved and added to the lipid. The vials were kept on a hot plate magnetic stirrer at 80 °C for 1 h, then the amount of ZP was determined spectrophotometrically (UV-1601 PC; Shimadzu, Kyoto, Japan)at λ max = 304 nm ( Zhou et al, 2020 ) after 10-folds dilution with methanol. The lipid with the maximum drug solubility was chosen for further preparation of NLCs.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone

Taha

Nour

Mamdouh

et al. 2023

International Journal of Pharmaceutics: X

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

“…The prepared NLCs were then dissolved in methanol ( Al-Attas et al, 2017 ) by sonication for 5 min. Entrapped ZP amount was then determined spectrophotometrically at λ max = 304 nm ( Zhou et al, 2020 ) by using an appropriate calibration curve of pure ZP in methanol, EE% is calculated as follows, Eq. 1:

100

…”

Section: Methodsmentioning

confidence: 99%

Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone

Taha

Nour

Mamdouh

et al. 2023

International Journal of Pharmaceutics: X

View full text Add to dashboard Cite

Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology

Wang

Jiao

Qing-chun

et al. 2021

Pharmaceutical Development and Technology

View full text Add to dashboard Cite

Supplementary file1. UV validation data of Propranolol hydrochloride 1.1 Selection of detection wavelength Accurately weigh an appropriate amount of Propranolol hydrochloride, dissolve and dilute it with pH 1.2 hydrochloric acid solution to obtain a test solution with the concentration of about 35 µg/mL. With pH 1.2 hydrochloric acid solution as the blank control, use an ultraviolet spectrophotometer to perform scanning within the wavelength range of 200-400 nm. The test result is shown in Figure 1-1.

show abstract

Pulsatile Drug Delivery Systems the Novel Approach

BODKE,

TEKADE,

BADEKAR

et al. 2024

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Oral pulsatile drug delivery systems (PDDS) are intended to induce programmable lag phases before a quick and quantifiable, repeated, or prolonged medication release. As a result, they are gaining popularity due to their inherent suitability for achieving chronotherapeutic goals, which have just been highlighted concerning several prevalent chronic illnesses characterized by typical night or early-morning recurring symptoms (e. g. bronchial asthma, heart attack, rheumatoid arthritis, early-morningawakening). Furthermore, time-based colonic release is possible when pulsatile delivery devices are correctly modified to overcome unexpected gastric emptying and give delay periods that roughly match the small intestine transit time. Oral pulsatile administration is accomplished using several release platforms, including reservoir, capsular, and osmotic devices. The current review article addressed the topics that followed: the reason pulsatile drug delivery systems have been invented; diseases for which pulsatile release is necessary; classification, advantages and disadvantages; methods used in the current systems; the situation nowadays and its potential for the future; recent advancements, and especially, the previous five to ten years of research on pulsatile drug delivery conducted by researchers using a variety of drugs for a variety of diseases.

show abstract

Development and evaluation of zopiclone compression coated tablet for time-controlled pulse release: Mechanism and in vivo study

Cited by 4 publications

References 27 publications

Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone

Cod liver oil nano-structured lipid carriers (Cod-NLCs) as a promising platform for nose to brain delivery: Preparation, in vitro optimization, ex vivo cytotoxicity & in vivo biodistribution utilizing radioiodinated zopiclone

Design and evaluation of a zero-order controlled release system based on pre-hydrated constant release area prepared by compression coating technology

Pulsatile Drug Delivery Systems the Novel Approach

Contact Info

Product

Resources

About